| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.005 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |